Abstract OBJECTIVES: To evaluate disease activity patterns and flare occurrence in a cohort of systemic lupus erythematosus (SLE) patients. METHODS: Patients registered in our lupus Database, diagnosed with SLE between 1991 and 2004 and followed up quarterly from 2004 to 2010 were considered in the study. Disease activity patterns were defined using SLE Disease Activity Index-2000 (SLEDAI-2K), excluding serology, as follows: clinical quiescent disease (CQD), SLEDAI-2K=0 in the three annual visits; minimal disease activity (MDA), SLEDAI-2K=1 in one or more annual visits; chronic active disease (CAD), SLEDAI-2K≥2 in at least two annual visits; relapsing-remitting disease (RRD), SLEDAI-2K≥2 in one out of 3 annual visits. Flare wa...
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
ObjectiveWe describe disease activity, damage, and the accrual of key autoantibodies in an inception...
Background: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE SLE is characterized by relapses and remissions. We aimed to describe the frequency, ty...
OBJECTIVE SLE is characterized by relapses and remissions. We aimed to describe the frequency, ty...
Objective: Systemic lupus erythematosus (SLE) is characterised by relapses and remissions. This stud...
Objective: SLE is characterized by relapses and remissions. We aimed to describe the frequency, type...
OBJECTIVES: Literature data suggest a significantly higher mortality in patients affected by system...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Objectives: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehe...
Abstract Background We sought to examine the disease course of High Disease Activity Status (HDAS) p...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
OBJECTIVE: To evaluate the prevalence, duration and effect on damage accrual of the 'Lupus Low Dise...
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
ObjectiveWe describe disease activity, damage, and the accrual of key autoantibodies in an inception...
Background: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
Objective: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE: Several indices have been proposed to assess disease activity in patients with Systemic L...
OBJECTIVE SLE is characterized by relapses and remissions. We aimed to describe the frequency, ty...
OBJECTIVE SLE is characterized by relapses and remissions. We aimed to describe the frequency, ty...
Objective: Systemic lupus erythematosus (SLE) is characterised by relapses and remissions. This stud...
Objective: SLE is characterized by relapses and remissions. We aimed to describe the frequency, type...
OBJECTIVES: Literature data suggest a significantly higher mortality in patients affected by system...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
Objectives: We evaluated a monocentric SLE cohort in order to assess the frequency of Lupus comprehe...
Abstract Background We sought to examine the disease course of High Disease Activity Status (HDAS) p...
Objective. SLE has a relapsing-remitting course with disease activity flares over time. This study a...
OBJECTIVE: To evaluate the prevalence, duration and effect on damage accrual of the 'Lupus Low Dise...
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...
ObjectiveWe describe disease activity, damage, and the accrual of key autoantibodies in an inception...
Background: Systemic lupus erythematosus (SLE) is a chronic heterogeneous disease with considerable ...